IFM Tre's Series A Round

IFM Tre raised a round of funding on July 19, 2018.

IFM Tre, a subsidiary of IFM Therapeutics, is a biopharmaceutical company developing a suite of small-molecule antagonists targeting inappropriate inflammatory responses of the innate immune system vi…

Articles about IFM Tre's Series A Round: